Neuber, B., Krämer, I., Tolliver, C., Schönland, S., Hegenbart, U., Hose, D., . . . Hundemer, M. (2011). Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma. The journal of immunology, 187(2), . https://doi.org/10.4049/jimmunol.1002460
Chicago Style (17th ed.) CitationNeuber, Brigitte, et al. "Lenalidomide Enhances Antigen-specific Activity and Decreases CD45RA Expression of T Cells from Patients with Multiple Myeloma." The Journal of Immunology 187, no. 2 (2011). https://doi.org/10.4049/jimmunol.1002460.
MLA (9th ed.) CitationNeuber, Brigitte, et al. "Lenalidomide Enhances Antigen-specific Activity and Decreases CD45RA Expression of T Cells from Patients with Multiple Myeloma." The Journal of Immunology, vol. 187, no. 2, 2011, https://doi.org/10.4049/jimmunol.1002460.